Ljungberg Börje, Hedin Oskar, Lundstam Sven, Warnolf Åsa, Mandahl Forsberg Annika, Hjelle Karin M, Stief Christian G, Borlinghaus Claudia, Beisland Christian, Staehler Michael
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Urology. 2016 Jul;93:117-23. doi: 10.1016/j.urology.2016.01.037. Epub 2016 Mar 24.
To evaluate the role of the surgical technique used for the treatment of benign renal tumors, with regard to renal function and overall survival (OS) in patients without cancer-related mortality.
The study included 506 patients, mean age of 63.3 years, with histologically proven benign renal lesions originating from 5 European centers. Retrospective data from each hospital were retrieved and merged into a common database for analyses. OS, American Society of Anesthesiology score, and renal functions were measured in relation to surgical technique. The Mann-Witney U-test, the paired t-test, and Cox's multivariate analysis were used.
Patients treated with radical nephrectomy had significantly reduced renal function postoperatively compared with nephron sparing surgery (NSS). OS was significantly reduced after radical nephrectomy compared with NSS (P = .012), a survival difference that remained significant [hazard ratio (HR) 0.042, 95% confidence interval (CI) 0.221-0.972, P = .042] in multivariate analysis, together with age at diagnosis (HR 1.065, 95% CI 1.026-1.106, P = .001) and American Society of Anesthesiology score (HR 2.361, 95% CI 1.261-4.419, P = .007). Also renal function assessed by estimated glomerular filtration rate significantly correlated to survival in univariate analysis, but did not remain independent after multivariate analysis. Oncocytoma was the most frequent benign lesion, followed by angiomyolipoma.
The present study in patients with benign renal tumors shows that the remaining renal function and OS correspond to the choice of surgical procedure. Our results support the recommendation to perform NSS whenever possible when surgery is performed for patients with renal masses. The limitations of the study are the retrospective design and the selection bias for the surgical approach.
评估用于治疗良性肾肿瘤的手术技术在无癌症相关死亡患者的肾功能和总生存期(OS)方面的作用。
该研究纳入了506例患者,平均年龄63.3岁,其组织学证实的良性肾病变源自5个欧洲中心。从每家医院检索回顾性数据并合并到一个共同数据库中进行分析。根据手术技术测量总生存期、美国麻醉医师协会评分和肾功能。采用曼-惠特尼U检验、配对t检验和Cox多变量分析。
与保留肾单位手术(NSS)相比,接受根治性肾切除术的患者术后肾功能显著降低。与NSS相比,根治性肾切除术后的总生存期显著降低(P = 0.012),在多变量分析中,这种生存差异仍然显著[风险比(HR)0.042,95%置信区间(CI)0.221 - 0.972,P = 0.042],同时还有诊断时的年龄(HR 1.065,95% CI 1.026 - 1.106,P = 0.001)和美国麻醉医师协会评分(HR 2.361,95% CI 1.261 - 4.419,P = 0.007)。此外,在单变量分析中,通过估计肾小球滤过率评估的肾功能与生存期显著相关,但在多变量分析后不再独立。嗜酸细胞瘤是最常见的良性病变,其次是肾血管平滑肌脂肪瘤。
本项针对良性肾肿瘤患者的研究表明,剩余肾功能和总生存期与手术方式的选择相关。我们的结果支持在对肾肿物患者进行手术时尽可能进行NSS的建议。该研究的局限性在于回顾性设计和手术方式的选择偏倚。